Literature DB >> 33673851

The role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors.

Yiyang Zheng1,2, Yanyan Luo1, Xixi Chen1, Huiting Li1, Baojun Huang1, Baofeng Zhou1, Liqing Zhu3, Xianhui Kang4, Wujun Geng5.   

Abstract

Neural tumors can generally be divided into central nervous system tumors and peripheral nervous tumors. Because this type of tumor is located in the nerve, even benign tumors are often difficult to remove by surgery. In addition, the majority of neural tumors are malignant, and it is particular the same for the central nervous system tumors. Even treated with the means such as chemotherapy and radiotherapy, they are also difficult to completely cure. In recent years, an increasingly number of studies have focused on the use of mRNA to treat tumors, representing an emerging gene therapy. The use of mRNA can use the expression of some functional proteins for the treatment of genetic disorders or tissue repair, and it can also be applied to immunotherapy through the expression of antigens, antibodies or receptors. Therefore, although these therapies are not fully-fledged enough, they have a broad research prospect. In addition, there are many ways to treat tumors using mRNA vaccines and exosomes carrying mRNA, which have drawn much attention. In this study, we reviewed the current research on the role of mRNA in the development, diagnosis, treatment and prognosis of neural tumors, and examine the future research prospects of mRNA in neural tumors and the opportunities and challenges that will arise in the future application of clinical treatment.

Entities:  

Keywords:  Gene regulation; Neural tumor; Tumor therapy; mRNA

Year:  2021        PMID: 33673851     DOI: 10.1186/s12943-021-01341-7

Source DB:  PubMed          Journal:  Mol Cancer        ISSN: 1476-4598            Impact factor:   27.401


  112 in total

Review 1.  Altered RNA Processing in Cancer Pathogenesis and Therapy.

Authors:  Esther A Obeng; Connor Stewart; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2019-10-14       Impact factor: 39.397

2.  Cancer's source in the peripheral nervous system.

Authors:  Peter B Dirks
Journal:  Nat Med       Date:  2008-04       Impact factor: 53.440

Review 3.  How Messenger RNA and Nascent Chain Sequences Regulate Translation Elongation.

Authors:  Junhong Choi; Rosslyn Grosely; Arjun Prabhakar; Christopher P Lapointe; Jinfan Wang; Joseph D Puglisi
Journal:  Annu Rev Biochem       Date:  2018-06-20       Impact factor: 23.643

4.  [Contribution of monoclonal antibody D 47 in the study of sweat gland pathology].

Authors:  J Kanitakis; D Schmitt; J Thivolet
Journal:  Ann Pathol       Date:  1985       Impact factor: 0.407

Review 5.  Progress in rare central nervous system tumors.

Authors:  Marta Penas-Prado; Terri S Armstrong; Mark R Gilbert
Journal:  Curr Opin Neurol       Date:  2019-12       Impact factor: 5.710

Review 6.  Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.

Authors:  Jayesh A Kulkarni; Dominik Witzigmann; Sam Chen; Pieter R Cullis; Roy van der Meel
Journal:  Acc Chem Res       Date:  2019-08-09       Impact factor: 22.384

Review 7.  MiRNA inhibition in tissue engineering and regenerative medicine.

Authors:  Kelsey R Beavers; Christopher E Nelson; Craig L Duvall
Journal:  Adv Drug Deliv Rev       Date:  2014-12-29       Impact factor: 15.470

Review 8.  Neuroma.

Authors:  Michael W Neumeister; James N Winters
Journal:  Clin Plast Surg       Date:  2020-01-31       Impact factor: 2.017

Review 9.  Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.

Authors:  Xinyi Zhang; Kai Xie; Honghua Zhou; Yuwei Wu; Chan Li; Yating Liu; Zhaoya Liu; Qian Xu; Shuang Liu; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

10.  Cancer prognosis with shallow tumor RNA sequencing.

Authors:  Pedro Milanez-Almeida; Andrew J Martins; Ronald N Germain; John S Tsang
Journal:  Nat Med       Date:  2020-02-10       Impact factor: 53.440

View more
  5 in total

Review 1.  Targeted contrast agents and activatable probes for photoacoustic imaging of cancer.

Authors:  Zhenxiang Zhao; Chelsea B Swartchick; Jefferson Chan
Journal:  Chem Soc Rev       Date:  2022-02-07       Impact factor: 60.615

2.  Role of Hub Genes in the Occurrence and Development of Testicular Cancer Based on Bioinformatics.

Authors:  Chunlei Zhang; Weijun Zhang; Han Cui; Bin Zhang; Pengcheng Miao; Qi Yang; Mei Bai; Hongmei Jiao; Dehui Chang
Journal:  Int J Gen Med       Date:  2022-01-18

Review 3.  Research Progress in the Application of Exosomes in Immunotherapy.

Authors:  Xiaofang Zhang; Donggang Xu; Yingqiu Song; Rong He; Tianlu Wang
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 4.  Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects.

Authors:  Tao Huang; Lushan Peng; Yingying Han; Dan Wang; Xiaoyun He; Junpu Wang; Chunlin Ou
Journal:  Front Immunol       Date:  2022-08-26       Impact factor: 8.786

5.  Screening of the Key Genes for the Progression of Liver Cirrhosis to Hepatocellular Carcinoma Based on Bioinformatics.

Authors:  Yuanbin Chen; Hongyan Qian; Xiao He; Jing Zhang; Song Xue; Yumeng Wu; Jian Chen; Xuming Wu; Suqing Zhang
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.